Product Information
VENLAFAXINE HCL 25 MG TABLET is a generic product labeled by Rising Pharma Holdings Inc., priced at $0.0785 per EA under NDC 57237017201. Its NADAC has been published 433 times since Mar 14, 2018.
Strength
25 mg/1
Manufacturer
Rising Pharma Holdings Inc.NDC
57237017201
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
VENLAFAXINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA090555On Market Since
4/7/2010
Pharmacological Classes
Price Statistics
The NADAC for VENLAFAXINE HCL 25 MG TABLET has been published 433 times since Mar 14, 2018, and over the history we have for it it has declined 62.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0785 per EA |
|---|---|
| All-time high | $0.2694 (Sep 11, 2019) |
| All-time low | $0.0488 (Jul 17, 2024) |
| 52-week high | $0.0835 |
| 52-week low | $0.0558 |
| Median price | $0.1031 |
| Average price | $0.1270 |
| Largest weekly change | +94.5% (Aug 19, 2020) |
| Weeks tracked | 433 |
| Tracking since | Mar 14, 2018 |
Generic Alternatives
The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of VENLAFAXINE HCL 25 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for VENLAFAXINE HCL 25 MG TABLET, manufactured by Rising Pharma Holdings Inc., is $0.0785 per EA (NDC 57237017201), effective Jun 24, 2026.
How has the price of VENLAFAXINE HCL 25 MG TABLET changed over time?
Over the history we have for it, the NADAC for VENLAFAXINE HCL 25 MG TABLET has declined 62.8%. It has been tracked across 433 weekly CMS publications since Mar 14, 2018.
What are the highest and lowest recorded NADAC prices for VENLAFAXINE HCL 25 MG TABLET?
Since Mar 14, 2018, the NADAC for VENLAFAXINE HCL 25 MG TABLET has ranged from a low of $0.0488 (Jul 17, 2024) to a high of $0.2694 (Sep 11, 2019), with a median of $0.1031 per EA.
Are there cheaper alternatives to VENLAFAXINE HCL 25 MG TABLET?
1 NADAC-published product shares the same active ingredient, strength, and dosage form as VENLAFAXINE HCL 25 MG TABLET, but none are currently priced below it.
Who manufactures VENLAFAXINE HCL 25 MG TABLET?
VENLAFAXINE HCL 25 MG TABLET (NDC 57237017201) is labeled by Rising Pharma Holdings Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification